Is Psychemedics Corp. (PMD) Stock at the Top of the Diagnostics & Research Industry?

Psychemedics Corp. (PMD) is around the middle of the Diagnostics & Research industry according to InvestorsObserver. PMD received an overall rating of 48, which means that it scores higher than 48 percent of all stocks. Psychemedics Corp. also achieved a score of 60 in the Diagnostics & Research industry, putting it above 60 percent of Diagnostics & Research stocks. Diagnostics & Research is ranked 66 out of the 148 industries.

PMD has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on PMD!

See Full PMD Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 48 would rank higher than 48 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Psychemedics Corp. Stock Today?

Psychemedics Corp. (PMD) stock has gained 5.29% while the S&P 500 is down -0.35% as of 2:16 PM on Tuesday, Sep 14. PMD has gained $0.40 from the previous closing price of $7.56 on volume of 83,938 shares. Over the past year the S&P 500 is higher by 31.60% while PMD has gained 70.82%. PMD lost -$0.26 per share the over the last 12 months. Click Here to get the full Stock Report for Psychemedics Corp. stock.